Extent of pre-operative L-DOPA-induced dyskinesia predicts the severity of graft-induced dyskinesia after fetal dopamine cell transplantation

Experimental Neurology

Volumn 232, Issue 2, 2011, Pages 270-279

  García, Joanna ^a   Carlsson, Thomas ^b,c,d   Döbrössy, Máté ^a   Nikkhah, Guido ^a   Winkler, Christian ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

6 OHDA; Abnormal ivoluntary movements; AIM; Graft induced side effects; Motor behavior; Parkinson's disease

Indexed keywords

AMPHETAMINE; APOMORPHINE; BENSERAZIDE; DOPAMINE; LEVODOPA; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG INDUCED DISEASE; DYSKINESIA; FEMALE; GRAFT INDUCED DYSKINESIA; IMMUNOHISTOCHEMISTRY; NONHUMAN; PARKINSON DISEASE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RAT;

AMPHETAMINES; ANIMALS; APOMORPHINE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE AGENTS; DOPAMINE AGONISTS; DOPAMINERGIC NEURONS; DYSKINESIA, DRUG-INDUCED; DYSKINESIAS; FEMALE; FETAL TISSUE TRANSPLANTATION; LEVODOPA; OXIDOPAMINE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; SUBSTANTIA NIGRA; SYMPATHOLYTICS;

EID: 80055001142     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.09.017     Document Type: Article

References (43)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 1946, 94:239-247.
2. Brundin P., Pogarell O., Hagell P., Piccini P., Widner H., Schrag A., Kupsch A., Crabb L., Odin P., Gustavii B., Björklund A., Brooks D.J., Marsden C.D., Oertel W.H., Quinn N.P., Rehncrona S., Lindvall O. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 2000, 123:1380-1390.
3. Brundin P., Barker R.A., Parmar M. Neural grafting in Parkinson's disease: problems and possibilities. Prog. Brain Res. 2010, 184:265-294.
4. Carlsson T., Winkler C., Lundblad M., Cenci M.A., Björklund A., Kirik D. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia. Neurobiol. Dis. 2006, 21:657-668.
5. Carlsson T., Carta M., Winkler C., Björklund A., Kirik D. Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. J. Neurosci. 2007, 27:8011-8022.
6. Cenci M.A., Lee C.S., Björklund A. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur. J. Neurosci. 1998, 10:2694-2706.
7. Cenci M.A., Konradi C. Maladaptive striatal plasticity in L-DOPA-induced dyskinesia. Prog. Brain Res. 2010, 183:209-233.
8. Defer G.L., Geny C., Ricolfi F., Fenelon G., Monfort J.C., Remy P., Villafane G., Jeny R., Samson Y., Keravel Y., Gaston A., Degos J.D., Peschanski M., Cesaro P., Nguyen J.P. Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 1996, 119:41-50.
9. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinsons disease. N. Engl. J. Med. 2001, 344:710-719.
10. Freed C.R., Breeze R.E., Fahn S., Eidelberg D. Preoperative response to levodopa is the best predictor of transplant outcome. Ann. Neurol. 2004, 55(6):896.
11. García J., Carlsson T., Döbrössy M., Nikkhah G., Winkler C. Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia. Neurobiol. Dis. 2011, 43:576-587.
12. Graff-Radford J., Foote K.D., Rodriguez R.L., Fernandez H.H., Hauser R.A., Sudhyadhom A., Rosado C.A., Sanchez J.C., Okun M.S. Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia. Arch. Neurol. 2006, 63(8):1181-1184.
13. Hagell P., Schrag A., Piccini P., Jahanshahi M., Brown R., Rehncrona S., Widner H., Brundin P., Rothwell J.C., Odin P., Wenning G.K., Morrish P., Gustavii B., Björklund A., Brooks D.J., Marsden C.D., Quinn N.P., Lindvall O. Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 1999, 122:1121-1132.
14. Hagell P., Piccini P., Björklund A., Brundin P., Rehncrona S., Widner H., Crabb L., Pavese N., Oertel W.H., Quinn N., Brooks D.J., Lindvall O. Dyskinesias following neural transplantation in Parkinson's disease. Nat. Neurosci. 2002, 5:627-628.
15. Hagell P., Cenci M.A. Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective. Brain Res. Bull. 2005, 68(1-2):4-15. 15.
16. Hauser R.A., Freeman T.B., Snow B.J., Nauert M., Gauger L., Kordower J.H., Olanow C.W. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch. Neurol. 1999, 56:179-187.
17. Herzog J., Pogarell O., Pinsker M.O., Kupsch A., Oertel W.H., Lindvall O., Deuschl G., Volkmann J. Deep brain stimulation in Parkinson's disease following fetal nigral transplantation. Mov. Disord. 2008, 23(9):1293-1296. 15.
18. Jacques D.B., Kopyov O.V., Eagle K.S., Carter T., Lieberman A. Outcomes and complications of fetal tissue transplantation in Parkinson's disease. Stereotact. Funct. Neurosurg. 1999, 72(2-4):219-224.
19. Kordower J.H., Chu Y., Hauser R.A., Freeman T.B., Olanow C.W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 2008, 14(5):504-506.
20. Lane E.L., Winkler C., Brundin P., Cenci M.A. The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat. Neurobiol. Dis. 2006, 22:334-345.
21. Lane E.L., Soulet D., Vercammen L., Cenci M.A., Brundin P. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease. Neurobiol. Dis. 2008, 32(2):220-228.
22. Lane E.L., Brundin P., Cenci M.A. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease. Neurobiol. Dis. 2009, 35(1):42-51.
23. Lane E.L., Vercammen L., Cenci M.A., Brundin P. Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats. Exp. Neurol. 2009, 219(1):355-358.
24. Lane E.L., Björklund A., Dunnett S.B., Winkler C. Neural grafting in Parkinson's disease: unraveling the mechanisms underlying graft-induced dyskinesia. Prog. Brain Res. 2010, 184:295-309.
25. Li J.Y., Englund E., Holton J.L., Soulet D., Hagell P., Lees A.J., Lashley T., Quinn N.P., Rehncrona S., Björklund A., Widner H., Revesz T., Lindvall O., Brundin P. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 2008, 14(5):501-503.
26. Ma Y., Feigin A., Dhawan V., Fukuda M., Shi Q., Greene P., Breeze R., Fahn S., Freed C., Eidelberg D. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann. Neurol. 2002, 52:628-634.
27. Ma Y., Tang C., Chaly T., Greene P., Breeze R., Fahn S., Freed C., Dhawan V., Eidelberg D. Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. J. Nucl. Med. 2010, 51(1):7-15.
28. Maries E., Kordower J.H., Chu Y., Collier T.J., Sortwell C.E., Olaru E., Shannon K., Steece-Collier K. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol. Dis. 2006, 21:165-180.
29. Mendez I., Dagher A., Hong M., Hebb A., Gaudet P., Law A., Weerasinghe S., King D., Desrosiers J., Darvesh S., Acorn T., Robertson H. Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations. J. Neurosurg. 2000, 92(5):863-869.
30. Mendez I., Viñuela A., Astradsson A., Mukhida K., Hallett P., Robertson H., Tierney T., Holness R., Dagher A., Trojanowski J.Q., Isacson O. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat. Med. 2008, 14(5):507-509.
31. Nikkhah G., Olsson M., Eberhard J., Bentlage C., Cunningham M.G., Björklund A. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 1994, 63:57-72.
32. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., Shannon K.M., Nauert G.M., Perl D.P., Godbold J., Freeman T.B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 2003, 54:403-414.
33. Olanow C.W., Gracies J.M., Goetz C.G., Stoessl A.J., Freeman T., Kordower J.H., Godbold J., Obeso J.A. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis. Mov. Disord. 2009, 24(3):336-343. 15.
34. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Academic, San Diego. 5 ed.
35. Piccini P., Pavese N., Hagell P., Reimer J., Björklund A., Oertel W.H., Quinn N.P., Brooks D.J., Lindvall O. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 2005, 128(Pt 12):2977-2986.
36. Politis M., Wu K., Loane C., Quinn N.P., Brooks D.J., Rehncrona S., Björklund A., Lindvall O., Piccini P. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci. Transl. Med. 2010, 2(38):38-46.
37. Steece-Collier K., Soderstrom K.E., Collier T.J., Sortwell C.E., Maries-Lad E. Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats. J. Comp. Neurol. 2009, 515(1):15-30.
38. Soderstrom K.E., Meredith G., Freeman T.B., McGuire S.O., Collier T.J., Sortwell C.E., Wu Q., Steece-Collier K. The synaptic impact of the host immune response in a parkinsonian allograft rat model: influence on graft-derived aberrant behaviors. Neurobiol. Dis. 2008, 32(2):229-242.
39. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 1970, 24(3):485-493.
40. Vinuela A., Hallett P.J., Reske-Nielsen C., Patterson M., Sotnikova T.D., Caron M.G., Gainetdinov R.R., Isacson O. Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-DOPA dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease. Brain 2008, 131:3361-3379.
41. Wenning G.K., Odin P., Morrish P., Rehncrona S., Widner H., Brundin P., Rothwell J.C., Brown R., Gustavii B., Hagell P., Jahanshahi M., Sawle G., Björklund A., Brooks D.J., Marsden C.D., Quinn N.P., Lindvall O. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 1997, 42(1):95-107.
42. Winkler C., Kirik D., Björklund A., Cenci M.A. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol. Dis. 2002, 10:165-186.
43. Winkler C., Kirik D., Björklund A. Cell transplantation in Parkinson's disease: how can we make it work?. Trends Neurosci. 2005, 28:86-92.